| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 1096 |
| 1 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 256 |
| 2 | PRODUCT DOSE OMISSION IN ERROR | 224 |
| 3 | PRODUCT USE ISSUE | 195 |
| 4 | ANXIETY | 155 |
| 5 | PAIN | 142 |
| 6 | DRUG INEFFECTIVE | 137 |
| 7 | RASH | 126 |
| 8 | FATIGUE | 122 |
| 9 | VIRAL LOAD INCREASED | 121 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | CYSTOSTOMY | 15 | 0.2679 |
| 1 | CD4 LYMPHOCYTE PERCENTAGE DECREASED | 4 | 0.0909 |
| 2 | HORMONE-DEPENDENT PROSTATE CANCER | 5 | 0.0714 |
| 3 | MONKEYPOX | 15 | 0.0543 |
| 4 | BLOOD HIV RNA INCREASED | 82 | 0.0452 |
| 5 | HYPERANDROGENISM | 4 | 0.0426 |
| 6 | CONGENITAL GENITAL MALFORMATION | 6 | 0.0375 |
| 7 | PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT | 32 | 0.0366 |
| 8 | INTERFERON GAMMA RELEASE ASSAY POSITIVE | 6 | 0.0366 |
| 9 | SYPHILIS | 25 | 0.0344 |